{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:33:07Z","timestamp":1785407587225,"version":"3.56.0"},"reference-count":65,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011576","name":"Inonu University Scientific Research Projects Coordination Unit","doi-asserted-by":"publisher","award":["TSA-2026-4607"],"award-info":[{"award-number":["TSA-2026-4607"]}],"id":[{"id":"10.13039\/501100011576","id-type":"DOI","asserted-by":"publisher"}]},{"award":["TSA-2026-4607"],"award-info":[{"award-number":["TSA-2026-4607"]}],"id":[{"id":"https:\/\/ror.org\/04asck240","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Immunosuppressive medication adherence is essential for maintaining graft function and long-term survival after liver transplantation, yet adherence may be influenced by treatment complexity, psychosocial burden, and post-transplant medication changes. Although once-daily tacrolimus (TAC) has been proposed as a regimen-simplification strategy, the relationship between TAC dosing frequency and adherence in liver transplant recipients remains insufficiently clarified. This study aimed to evaluate the association between TAC dosing frequency and medication adherence in liver transplant (LT) recipients and to compare psychosocial characteristics, immunosuppressive treatment patterns, and post-transplant medication stability between dosing regimens. Materials and Methods: This cross-sectional study included 231 LT recipients followed at the Inonu University Liver Transplantation Institute. Patients were categorized according to TAC dosing regimen as once-daily (n = 121) or twice-daily (n = 110) use. Data were collected through structured telephone interviews using the validated Immunosuppressive Medication Adherence Scale (IMAS), together with demographic, clinical, psychosocial, treatment-related, and socioeconomic variables. Results: Most demographic and anthropometric characteristics were comparable between once-daily and twice-daily TAC groups, and mean IMAS total scores did not differ between groups (p = 0.785), indicating similar levels of self-reported medication adherence. In contrast, anxiety or depressive disorders were more frequent among once-daily TAC recipients (p = 0.045), and everolimus use was higher in this group (p = 0.025). Frequent post-transplant immunosuppressive medication changes were markedly more common among once-daily recipients (p &lt; 0.001), and low monthly income was also more prevalent (p = 0.002). In subgroup comparisons, lower IMAS scores were observed in recipients experiencing frequent medication changes (p = 0.011) and in those who had not received medication-related education from healthcare professionals (p = 0.013). In univariate general linear model analyses, IMAS scores were not associated with TAC dosing regimen or sociodemographic characteristics, whereas frequency of immunosuppressive medication changes (p = 0.012), source of support for medication management (p = 0.048), and receipt of medication-related education from healthcare professionals (p = 0.036) were significantly associated with IMAS scores. In multivariable linear regression, frequent medication changes (p = 0.017), source of support for medication management (p = 0.028), and receipt of medication-related education (p = 0.019) remained independently associated with IMAS scores. Conclusions: TAC dosing frequency was not associated with self-reported medication adherence in LT recipients. Lower IMAS scores were associated with frequent post-transplant immunosuppressive medication changes, the need for external support in medication management, and lack of medication-related education from healthcare professionals. Compared with the twice-daily group, once-daily TAC recipients more frequently reported anxiety\/depressive disorders, everolimus use, frequent medication changes, and low income, despite similar IMAS scores.<\/jats:p>","DOI":"10.3390\/medicina62071391","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:47:32Z","timestamp":1784508452000},"page":"1391","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Factors Associated with Immunosuppressive Adherence in Liver Transplant Recipients Treated with Once- and Twice-Daily Tacrolimus"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6864-7711","authenticated-orcid":false,"given":"Sami","family":"Akbulut","sequence":"first","affiliation":[{"name":"Department of Surgery and Liver Transplantation Institute, Faculty of Medicine, Inonu University, Malatya 44280, T\u00fcrkiye"},{"name":"Department of Biostatistics and Medical Informatics, Faculty of Medicine, Inonu University, Malatya 44280, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betul","family":"Ozdemir","sequence":"additional","affiliation":[{"name":"Department of Public Health, Faculty of Nursing, Inonu University, Malatya 44280, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2203-5223","authenticated-orcid":false,"given":"Ummuhan","family":"Akturk","sequence":"additional","affiliation":[{"name":"Department of Public Health, Faculty of Nursing, Inonu University, Malatya 44280, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8237-9701","authenticated-orcid":false,"given":"Kemal Baris","family":"Sarici","sequence":"additional","affiliation":[{"name":"Department of Surgery and Liver Transplantation Institute, Faculty of Medicine, Inonu University, Malatya 44280, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.transproceed.2023.02.064","article-title":"Immunosuppressive Medication Adherence in Patients With Hepatocellular Cancer Who Have Undergo Liver Transplantation: A Case Control Study","volume":"55","author":"Akbulut","year":"2023","journal-title":"Transplant. Proc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"121862","DOI":"10.4061\/2011\/121862","article-title":"Indications and contraindications for liver transplantation","volume":"2011","author":"Varma","year":"2011","journal-title":"Int. J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/hep.20704","article-title":"AASLD practice guidelines: Evaluation of the patient for liver transplantation","volume":"41","author":"Murray","year":"2005","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"93253","DOI":"10.5500\/wjt.v15.i1.93253","article-title":"Lesson learnt from 60 years of liver transplantation: Advancements, challenges, and future directions","volume":"15","author":"Gadour","year":"2025","journal-title":"World J. Transplant."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1399-3046.2008.00901.x","article-title":"Adherence and health-related quality of life in adolescent liver transplant recipients","volume":"12","author":"Fredericks","year":"2008","journal-title":"Pediatr. Transplant."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/tri.12737","article-title":"Biopsy-proven acute cellular rejection as an efficacy endpoint of randomized trials in liver transplantation: A systematic review and critical appraisal","volume":"29","author":"Tsochatzis","year":"2016","journal-title":"Transpl. Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jceh.2017.10.003","article-title":"Acute and Chronic Rejection After Liver Transplantation: What a Clinician Needs to Know","volume":"7","author":"Choudhary","year":"2017","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"7771","DOI":"10.3748\/wjg.v27.i45.7771","article-title":"Chronic rejection after liver transplantation: Opening the Pandora\u2019s box","volume":"27","author":"Angelico","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/ctr.12119","article-title":"Completely steroid-free immunosuppression in liver transplantation: A randomized study","volume":"27","author":"Ramirez","year":"2013","journal-title":"Clin. Transplant."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1111\/j.1600-6143.2010.03164.x","article-title":"ATG-Fresenius treatment and low-dose tacrolimus: Results of a randomized controlled trial in liver transplantation","volume":"10","author":"Lozano","year":"2010","journal-title":"Am. J. Transplant."},{"key":"ref_11","first-page":"301","article-title":"Is there an association between immunosuppressant therapy medication adherence and depression, quality of life, and personality traits in the kidney and liver transplant population?","volume":"7","author":"Gorevski","year":"2013","journal-title":"Patient Prefer. Adherence"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000453554","article-title":"The Impact of Health Care Appointment Non-Adherence on Graft Outcomes in Kidney Transplantation","volume":"45","author":"Taber","year":"2017","journal-title":"Am. J. Nephrol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"a015487","DOI":"10.1101\/cshperspect.a015487","article-title":"Immunosuppressive drug therapy","volume":"3","author":"Hartono","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.transproceed.2017.02.049","article-title":"Predictors of Non-adherence to Immunosuppressive Therapy in Asian Liver Transplant Recipients","volume":"49","author":"Hartono","year":"2017","journal-title":"Transplant. Proc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.1399-0012.2010.01358.x","article-title":"Taking immunosuppressive medications effectively (TIMELink): A pilot randomized controlled trial in adult kidney transplant recipients","volume":"25","author":"Russell","year":"2011","journal-title":"Clin. Transplant."},{"key":"ref_16","first-page":"281","article-title":"Immunosuppressive drugs after solid organ transplantation","volume":"71","author":"Bemelman","year":"2013","journal-title":"Neth. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/TP.0b013e3182962cc1","article-title":"Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): A phase 2 trial of stable renal transplant recipients","volume":"96","author":"Gaber","year":"2013","journal-title":"Transplantation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/ajt.12019","article-title":"OPTN\/SRTR 2011 Annual Data Report: Kidney","volume":"13","author":"Matas","year":"2013","journal-title":"Am. J. Transplant."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s40265-019-01217-7","article-title":"Once-Daily versus Twice-Daily tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies","volume":"79","author":"Vadcharavivad","year":"2019","journal-title":"Drugs"},{"key":"ref_20","first-page":"CD003961","article-title":"Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients","volume":"19","author":"Webster","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"254","DOI":"10.5500\/wjt.v13.i5.254","article-title":"Impact of tacrolimus intra-patient variability in adverse outcomes after organ transplantation","volume":"13","author":"Morais","year":"2023","journal-title":"World J. Transplant."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1111\/ajt.16002","article-title":"A comprehensive review of the impact of tacrolimus intrapatient variability on clinical outcomes in kidney transplantation","volume":"20","author":"Gonzales","year":"2020","journal-title":"Am. J. Transplant."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2008.08.021","article-title":"Novel double coated nanocapsules for intestinal delivery and enhanced oral bioavailability of tacrolimus, a P-gp substrate drug","volume":"133","author":"Nassar","year":"2009","journal-title":"J. Control. Release"},{"key":"ref_24","first-page":"317","article-title":"Tacrolimus Dose-Conversion Ratios Based on Switching of Formulations for Patients with Solid Organ Transplants","volume":"74","author":"Kuan","year":"2021","journal-title":"Can. J. Hosp. Pharm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.transproceed.2005.03.017","article-title":"Factors contributing to acute rejection in renal transplantation: The role of noncompliance","volume":"37","author":"Morrissey","year":"2005","journal-title":"Transplant. Proc."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Karaterzi, S., T\u00f6nshoff, B., Ahlenstiel-Grunow, T., Baghai, M., Beck, B., B\u00fcscher, A., Eifler, L., Giese, T., Lezius, S., and M\u00fcller, C. (2024). A multi-center interventional study to assess pharmacokinetics, effectiveness, and tolerability of prolonged-release tacrolimus after pediatric kidney transplantation: Study protocol for a prospective, open-label, randomized, two-phase, two-sequence, single dose, crossover, phase III b trial. Front. Nephrol., 4.","DOI":"10.3389\/fneph.2024.1331510"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e2778","DOI":"10.1590\/1518-8345.1072.2778","article-title":"Adherence to immunosuppressive therapy following liver transplantation: An integrative review","volume":"24","author":"Oliveira","year":"2016","journal-title":"Rev. Lat. Am. Enfermagem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.transproceed.2015.12.100","article-title":"Systematic Pharmaceutical Educational Approach to Enhance Drug Adherence in Liver Transplant Recipients","volume":"48","author":"Asavakarn","year":"2016","journal-title":"Transplant. Proc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.transproceed.2015.12.097","article-title":"Immunosuppressive Medication Adherence in Liver Transplant Recipients","volume":"48","author":"Promraj","year":"2016","journal-title":"Transplant. Proc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1097\/MEG.0000000000001435","article-title":"Immunosuppressive drug withdrawal late after liver transplantation improves the lipid profile and reduces infections","volume":"31","author":"Duizendstra","year":"2019","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/SGA.0000000000000571","article-title":"The Effect of Immunosuppressant Therapy Adherence on the Comfort of Liver Transplant Recipients","volume":"44","year":"2021","journal-title":"Gastroenterol. Nurs."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/nep.13214","article-title":"Investigating barriers to immunosuppressant medication adherence in renal transplant patients","volume":"24","author":"Cossart","year":"2019","journal-title":"Nephrology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5152\/turkjnephrol.2019.3371","article-title":"Development and psychometric testing of the Turkish immunosuppressive medication adherence scale","volume":"28","author":"Talas","year":"2019","journal-title":"Turk. J. Nephrol."},{"key":"ref_34","first-page":"88","article-title":"Immunosuppressive medication adherence in liver transplant patients: A single center experience","volume":"4","author":"Karahan","year":"2020","journal-title":"Ahi Evran Med. J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.ijsu.2014.07.014","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration","volume":"12","author":"Vandenbroucke","year":"2014","journal-title":"Int. J. Surg."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Lakens, D. (2013). Calculating and reporting effect sizes to facilitate cumulative science: A practical primer for t-tests and ANOVAs. Front. Psychol., 4.","DOI":"10.3389\/fpsyg.2013.00863"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4300\/JGME-D-12-00156.1","article-title":"Using Effect Size-or Why the P Value Is Not Enough","volume":"4","author":"Sullivan","year":"2012","journal-title":"J. Grad. Med. Educ."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Smakowski, A., Rosmalen, J., L\u00f6we, B., Burton, C., and Toussaint, A. (2025). Empirical assessment of functional somatic disorder (FSD): Frequency, applicability, and diagnostic refinement in a population-based sample. BMC Med., 23.","DOI":"10.1186\/s12916-025-04042-w"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.edurev.2010.12.001","article-title":"Eta squared and partial eta squared as measures of effect size in educational research","volume":"6","author":"Richardson","year":"2011","journal-title":"Educ. Res. Rev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.transproceed.2007.06.042","article-title":"Recurrence of hepatocellular carcinoma after liver transplantation","volume":"39","author":"Escartin","year":"2007","journal-title":"Transplant. Proc."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2165\/00003495-200767100-00007","article-title":"Medication noncompliance and its implications in transplant recipients","volume":"67","author":"Morrissey","year":"2007","journal-title":"Drugs"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/lt.20828","article-title":"Adherence to medication after liver transplantation in Scotland: A pilot study","volume":"12","author":"McGregor","year":"2006","journal-title":"Liver Transplant."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1002\/lt.21900","article-title":"Outcomes after liver transplantation: Chronic kidney disease","volume":"15","author":"Bahirwani","year":"2009","journal-title":"Liver Transplant."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jhep.2014.03.034","article-title":"Chronic kidney disease and associated mortality after liver transplantation\u2014A time-dependent analysis using measured glomerular filtration rate","volume":"61","author":"Allen","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e1612","DOI":"10.1097\/TXD.0000000000001612","article-title":"Modifying tacrolimus-related Toxicity After Liver Transplantation Comparing Life Cycle Pharma tacrolimus Versus Extended-released tacrolimus: A Multicenter, Randomized Controlled Trial","volume":"10","author":"Mulder","year":"2024","journal-title":"Transplant. Direct"},{"key":"ref_46","first-page":"338","article-title":"Management of tacrolimus-Induced Toxicity With Normal Serum Levels After Liver Transplant","volume":"22","author":"Majid","year":"2024","journal-title":"Exp. Clin. Transplant."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3350\/cmh.2014.20.2.192","article-title":"Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation","volume":"20","author":"Lee","year":"2014","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jhep.2005.12.027","article-title":"Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation","volume":"45","author":"Unitt","year":"2006","journal-title":"J. Hepatol."},{"key":"ref_49","first-page":"927","article-title":"Evaluation of the Adherence of Patients to Immunosuppressive Drug Therapy After Liver Transplantation","volume":"22","author":"Kaya","year":"2024","journal-title":"Exp. Clin. Transplant."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5152\/jern.2023.21105","article-title":"Factors Affecting Adherence of Recipients to Immunosuppressive Therapy after Liver and Kidney Transplantation","volume":"20","author":"Tatoglu","year":"2023","journal-title":"J. Educ. Res. Nurs."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2147\/PPA.S398770","article-title":"Factors Affecting Immunosuppressive Medication Adherence in Liver Transplant Recipients with Poor Adherence: A Qualitative Study","volume":"17","author":"Karahan","year":"2023","journal-title":"Patient Prefer. Adherence"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"550","DOI":"10.18621\/eurj.1541361","article-title":"Immunosuppressive medication adherence and affecting factors in solid organ transplantation patients: A mixed-methods study","volume":"10","author":"Gunduz","year":"2024","journal-title":"Eur. Res. J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1432-2277.2011.01254.x","article-title":"Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice-daily tacrolimus-based regimen to once-daily tacrolimus extended-release formulation","volume":"24","author":"Beckebaum","year":"2011","journal-title":"Transpl. Int."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1681\/ASN.2004121059","article-title":"Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation","volume":"16","author":"Weng","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4254\/wjh.v13.i3.375","article-title":"Efficacy and safety of once daily tacrolimus compared to twice daily tacrolimus after liver transplantation","volume":"13","author":"Bzeizi","year":"2021","journal-title":"World J. Hepatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e14178","DOI":"10.1111\/jep.14178","article-title":"Impact of text message reminders on immunosuppressive medication adherence among kidney transplant recipients: A randomized controlled study","volume":"31","author":"Erdal","year":"2025","journal-title":"J. Eval. Clin. Pract."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e70021","DOI":"10.1111\/jep.70021","article-title":"Determining the Relationship Between Perceived Social Support and Immunosuppressive Medication Adherence After Kidney Transplantation: A Descriptive Correlational Study","volume":"31","author":"Karazeybek","year":"2025","journal-title":"J. Eval. Clin. Pract."},{"key":"ref_58","first-page":"678","article-title":"Examination of the Effect of Health Perception on Adherence to Immunosuppressive Medication Use in Kidney Transplant Patients","volume":"15","author":"Akkurt","year":"2025","journal-title":"Lokman Hekim J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1097\/01.tp.0000542651.41619.91","article-title":"Evaluate to the Efficacy and Effectiveness of Different Assessment Methods on Medication Adherence in Kidney Transplant Recipients","volume":"102","author":"Ordin","year":"2018","journal-title":"Transplantation"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.transproceed.2025.03.005","article-title":"The Effect of Web-Based Education on Symptoms and Adherence to Immunosuppressive Medications in Liver Transplant Patients","volume":"57","author":"Dolanbay","year":"2025","journal-title":"Transplant. Proc."},{"key":"ref_61","first-page":"115","article-title":"The effects of illness perception on immunosuppressive medication adherence in patients undergoing liver transplantation","volume":"14","author":"Kilinc","year":"2026","journal-title":"J. \u0130n\u00f6n\u00fc Univ. Health Serv. Vocat. Sch."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/TP.0000000000004574","article-title":"Psychometric Properties of the BAASIS: A Meta-analysis of Individual Participant Data","volume":"107","author":"Denhaerynck","year":"2023","journal-title":"Transplantation"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Shafiekhani, M., Shahabinezhad, F., Tavakoli, Z., Tarakmeh, T., Haem, E., Sari, N., Nasirabadi, S., and Dehghani, M. (2023). Quality of life associated with immunosuppressant treatment adherence in liver transplant recipients: A cross-sectional study. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1051350"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Maurer, M.M., Ibach, M., Plewe, J., Winter, A., Ritschl, P., Globke, B., \u00d6llinger, R., Lurje, G., Sch\u00f6ning, W., and Pratschke, J. (2022). Reducing the Pill Burden: Immunosuppressant Adherence and Safety after Conversion from a Twice-Daily (IR-Tac) to a Novel Once-Daily (LCP-Tac) tacrolimus Formulation in 161 Liver Transplant Patients. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020272"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"7915781","DOI":"10.1155\/2023\/7915781","article-title":"Improved Medication Adherence with the Use of Extended-Release tacrolimus in Liver Transplant Recipients: A Pilot Randomized Controlled Trial","volume":"2023","author":"Verma","year":"2023","journal-title":"J. Transplant."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/7\/1391\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T01:20:09Z","timestamp":1784510409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/7\/1391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":65,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["medicina62071391"],"URL":"https:\/\/doi.org\/10.3390\/medicina62071391","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,18]]}}}